Investigators evaluated the risk for hepatocellular carcinoma after direct-acting antivirals (DAA)-cured hepatitis C virus (HCV) in DAA-naive adults with HIV-HCV coinfection and advanced fibrosis.

The FDA approved perioperative durvalumab with FLOT chemotherapy for eligible patients with resectable Stage II-IVA gastric and GEJ cancers.

Tyruko (natalizumab-sztn), a biosimilar to Tysabri (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.

The FDA has approved Linzess (linaclotide) for treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older.

Intravenous anesthesia for painless gastroscopy among older adults is associated with lower postoperative cognitive dysfunction.

Olezarsen receives FDA Breakthrough Therapy status for adults with severe hypertriglyceridemia following positive results from CORE and CORE2 trials.

The World Health Organization's new strategic initiative focused on how to harness digital health technologies to improve health.

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

A manufacturing issue with Abbott FreeStyle Libre 3 sensors led to inaccurate readings, affecting about 3 million sensors worldwide.

Women with prepregnancy obesity are more likely to have children with neurodevelopmental disabilities, specifically showing greater risks for epilepsy and intellectual disability. Women with ...

GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.